Dyax drug for rare swelling disease approved for use in younger patients By: Boston Business Journal via Business Journals April 04, 2014 at 14:51 PM EDT U.S. regulators have approved a drug for an inherited, rare swelling disease called angioedema made by Dyax Corp... Read More >>